postmenopausal [tmco]
Oral [spco]
17 beta-Estradiol [horm, phsu, strd]
Combined [qlco]
Dydrogesterone [horm, phsu, strd]
Fasting [fndg]
Serum homocystine level [lbpr]
Objective [inpr]
investigate [ftcn]
effects [qlco]
Administration, Oral [topp]
17 beta-Estradiol [horm, phsu, strd]
Combined [qlco]
Dydrogesterone [horm, phsu, strd]
Fasting [fndg]
Serum homocystine level [lbpr]
postmenopausal [tmco]
Women [popg]
Design [acty]
randomized [resa]
Double-Blind Study [resa]
setting [ftcn]
Gynecologic [spco]
Out-patient [podg]
Department [orgt]
university hospital [hcro, mnob]
Five [qnco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
intervention [hlca]
Oral [spco]
17 beta-Estradiol [horm, phsu, strd]
2-D [spco]
mg% [qnco]
Combined [qlco]
Dosages [qnco]
Dydrogesterone [horm, phsu, strd]
2 5 [qnco]
mg% [qnco]
N NOS [aapp, imft]
mg% [qnco]
N NOS [aapp, imft]
mg% [qnco]
N NOS [aapp, imft]
mg% [qnco]
N NOS [aapp, imft]
GIVEN [cnce]
months [tmco]
Main [qlco]
outcome measure [qnco]
Fasting [fndg]
Serum.total [lbtr]
homocysteine [aapp, bacs]
Concentrations [menp]
Fasting [fndg]
Serum.total [lbtr]
homocysteine [aapp, bacs]
Concentrations [menp]
Study Population [popg]
Decreased [qnco]
months [tmco]
treatment [ftcn]
Unchanged [fndg]
influential [idcn]
Dydrogesterone [horm, phsu, strd]
Dosage [qnco]
Greatest [qnco]
reduction [npop]
homocysteine [aapp, bacs]
Concentration [menp]
Obtained [ftcn]
Women [popg]
Highest [qlco]
baseline [bodm]
Combined [qlco]
Hormone replacement therapy [topp]
lowers [spco]
Fasting [fndg]
Serum homocystine level [lbpr]
postmenopausal [tmco]
Women [popg]
Decrease [qlco]
Mechanisms [ftcn]
effects [qlco]
Hormone Replacement Therapy, Post-Menopausal [topp]
American [popg]
society [orgt]
Reproductive Medicine [bmod]
